Hepatitis C

Top Story

New HCV infection less common in MSM initiating PrEP

New HCV infection less common in MSM initiating PrEP
November 11, 2019
Meeting NewsVideo

VIDEO: Shorter duration Mavyret safe, effective in all HCV genotypes

November 11, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Robert S. Brown Jr., MD, MPH, of Weill Cornell Medical College, discusses the results of the…
Meeting News

Combination therapy prevents HCV infection in non-viremic organ recipients

November 10, 2019
BOSTON — Hepatitis C infection was prevented or rapidly cured in transplant recipients who received organs from donors infected with the virus following combined…
In the Journals

Albumin, liver stiffness after DAA therapy for HCV stratify liver cancer risk

November 8, 2019
Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients with hepatitis C and…
More Headlines »

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

VIDEO: Increased surveillance fuels hepatitis elimination in Africa

April 29, 2019
More »
Healio Jobs